Skip to main content
. 2017 Jul 8;17(6):167–170. doi: 10.1016/j.ipej.2017.07.002

Fig. 1.

Fig. 1

Comparison of defibrillation thresholds (DFTs) between control and methamphetamine cardiomyopathy (MACMP) patients is shown. Significantly higher DFTs were found in the MACMP population (23.7 ± 6.7 vs 14.7 ± 4.6, p < 0.005).